Steven Cohen's ZBIO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 368,400 shares of Zenas BioPharma, Inc. (ZBIO) worth $9.21 M, representing 0.01% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in ZBIO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 368,400 shares. Largest reduction occurred in Q4 2024, reducing 57,600 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Zenas BioPharma (ZBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zenas BioPharma (ZBIO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +368,400 | New Buy | 368,400 | $25.01 |
| Q4 2024 | -57,600 | Sold Out | 0 | $0.00 |
| Q3 2024 | +57,600 | New Buy | 57,600 | $16.92 |
Steven Cohen's Zenas BioPharma Investment FAQs
Steven Cohen first purchased Zenas BioPharma, Inc. (ZBIO) in Q3 2024, acquiring 57,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Zenas BioPharma, Inc. (ZBIO) for 3 quarters since Q3 2024.
Steven Cohen's largest addition to Zenas BioPharma, Inc. (ZBIO) was in Q4 2025, adding 368,400 shares worth $9.21 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 368,400 shares of Zenas BioPharma, Inc. (ZBIO), valued at approximately $9.21 M.
As of the Q4 2025 filing, Zenas BioPharma, Inc. (ZBIO) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Zenas BioPharma, Inc. (ZBIO) was 368,400 shares, as reported at the end of Q4 2025.